Ki-26894

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameKi-26894
Drug Alias NameTGFbeta receptor kinase-1 inhibitor (Kirin Brewery)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTGF-β activated kinase-1 inhibitors
TargetsTGF-β activated kinase-1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKirin Brewery Company Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKirin Brewery Company Ltd
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A